A Long-Acting Formulation of Rifabutin Is Effective for Prevention and Treatment of Mycobacterium tuberculosis

Scientists showed the development of long-acting injectable drug formulations of the anti-Tuberculosis drug rifabutin made of biodegradable polymers and biocompatible solvents that solidified after subcutaneous injection.